Label: LORATADINE tablet

  • Category: HUMAN OTC DRUG LABEL
  • DEA Schedule: None
  • Marketing Status: Abbreviated New Drug Application

Drug Label Information

Updated September 23, 2024

If you are a consumer or patient please visit this version.

View All Sections
  •    

    Original Prescription Strength Non-Drowsy*

    Indoor and Outdoor Allergies

    *When taken as directed. See Drug Facts Panel.

    TAMPER EVIDENT: DO NOT USE IF BLISTER UNITS ARE TORN, BROKEN OR SHOW ANY SIGNS OF TAMPERING.

  • Active Ingredient (in each tablet)

    Loratadine USP, 10 mg

  • Purpose

    Antihistamine

  • Uses

    temporarily relieves these symptoms due to hay fever or other upper respiratory allergies:

    • runny nose
    • itchy, watery eyes
    • sneezing
    • itching of the nose or throat
  • Warnings

    Do not use

    if you have ever had an allergic reaction to this product or any of its ingredients.

    Ask a doctor before use if you have

    liver or kidney disease. Your doctor should determine if you need a different dose.

    When using this product

    do not take more than directed. Taking more than directed may cause drowsiness.

    Stop use and ask a doctor if

    an allergic reaction to this product occurs. Seek medical help right away.

    If pregnant or breast-feeding,

    ask a health professional before use

    Keep out of reach of children

    In case of overdose, get medical help or contact a Poison Control Center right away.

  • Directions (24 Hour Relief)

    adults and children
    6 years and over

    1 tablet daily; not more
    than 1 tablet in 24 hours

    children under 6 years of age

    ask a doctor

    consumers with liver
    or kidney disease

    ask a doctor
  • Other information

    • TAMPER EVIDENT: DO NOT USE IF BLISTER UNITS ARE TORN, BROKEN OR SHOW ANY SIGNS OF TAMPERING.
    • Store at 20° to 25°C (68° to 77°F). [See USP Controlled Room Temperature.]
    • protect from excessive moisture
  • Inactive Ingredients

    Corn starch, lactose monohydrate and magnesium stearate.

  • Questions or comments?

    1-800-848-0462

    • Serious side effects associated with use of this product may be reported to this number.

    Manufactured for:
    Mylan Pharmaceuticals Inc.
    Morgantown, WV 26505 U.S.A.

    Made in India

    Code No.: MH/DRUGS/25/NKD/89

    Distributed by:
    Mylan Institutional Inc.
    Rockford, IL 61103 U.S.A.

    S-11333 R3
    1/21

  •      

    PRINCIPAL DISPLAY PANEL – 10 mg

    NDC 51079-246-20

    Loratadine
    Tablets, USP
    10 mg

    Antihistamine

    Original Prescription Strength    Non-Drowsy*

    Indoor and Outdoor Allergies

    24 Hour Relief(See Uses section of enclosed leaflet)

    *When taken as directed. See enclosed leaflet.

    TAMPER EVIDENT: DO NOT USE IF BLISTER UNITS ARE
    TORN, BROKEN OR SHOW ANY SIGNS OF TAMPERING.

    Loratadine Tablets 10 mg Carton Label
    Outer Carton Label
  • INGREDIENTS AND APPEARANCE
    LORATADINE 
    loratadine tablet
    Product Information
    Product TypeHUMAN OTC DRUGItem Code (Source)NDC:51079-246(NDC:0378-8880)
    Route of AdministrationORAL
    Active Ingredient/Active Moiety
    Ingredient NameBasis of StrengthStrength
    LORATADINE (UNII: 7AJO3BO7QN) (LORATADINE - UNII:7AJO3BO7QN) LORATADINE10 mg
    Inactive Ingredients
    Ingredient NameStrength
    STARCH, CORN (UNII: O8232NY3SJ)  
    LACTOSE MONOHYDRATE (UNII: EWQ57Q8I5X)  
    MAGNESIUM STEARATE (UNII: 70097M6I30)  
    Product Characteristics
    Colorwhite (white to off-white) Scoreno score
    ShapeROUNDSize6mm
    FlavorImprint Code G;L;10
    Contains    
    Packaging
    #Item CodePackage DescriptionMarketing Start DateMarketing End Date
    1NDC:51079-246-20100 in 1 BOX, UNIT-DOSE04/30/2013
    1NDC:51079-246-011 in 1 BLISTER PACK; Type 0: Not a Combination Product
    Marketing Information
    Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
    ANDAANDA07615404/30/2013
    Labeler - Mylan Institutional Inc. (039615992)
View All Sections

Find additional resources

(also available in the left menu)

Safety

Report Adverse Events, FDA Safety Recalls, Presence in Breast Milk

Related Resources

Medline Plus, Clinical Trials, PubMed, Biochemical Data Summary

More Info on this Drug

View Labeling Archives, RxNorm, Get Label RSS Feed, View NDC Code(s)NEW!